These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 16146765)

  • 1. The WNT/Beta-catenin pathway in melanoma.
    Larue L; Delmas V
    Front Biosci; 2006 Jan; 11():733-42. PubMed ID: 16146765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression.
    Schepsky A; Bruser K; Gunnarsson GJ; Goodall J; Hallsson JH; Goding CR; Steingrimsson E; Hecht A
    Mol Cell Biol; 2006 Dec; 26(23):8914-27. PubMed ID: 17000761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/β-catenin signaling is stimulated by α-melanocyte-stimulating hormone in melanoma and melanocyte cells: implication in cell differentiation.
    Bellei B; Pitisci A; Catricalà C; Larue L; Picardo M
    Pigment Cell Melanoma Res; 2011 Apr; 24(2):309-25. PubMed ID: 21040502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brn-2 expression controls melanoma proliferation and is directly regulated by beta-catenin.
    Goodall J; Martinozzi S; Dexter TJ; Champeval D; Carreira S; Larue L; Goding CR
    Mol Cell Biol; 2004 Apr; 24(7):2915-22. PubMed ID: 15024079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model.
    Chien AJ; Moore EC; Lonsdorf AS; Kulikauskas RM; Rothberg BG; Berger AJ; Major MB; Hwang ST; Rimm DL; Moon RT
    Proc Natl Acad Sci U S A; 2009 Jan; 106(4):1193-8. PubMed ID: 19144919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor suppressor HINT1 regulates MITF and β-catenin transcriptional activity in melanoma cells.
    Genovese G; Ghosh P; Li H; Rettino A; Sioletic S; Cittadini A; Sgambato A
    Cell Cycle; 2012 Jun; 11(11):2206-15. PubMed ID: 22647378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma.
    Bonvin E; Falletta P; Shaw H; Delmas V; Goding CR
    Mol Cell Biol; 2012 Nov; 32(22):4674-83. PubMed ID: 22988297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of β-catenin signaling in the anti-invasive effect of the omega-3 fatty acid DHA in human melanoma cells.
    Serini S; Zinzi A; Ottes Vasconcelos R; Fasano E; Riillo MG; Celleno L; Trombino S; Cassano R; Calviello G
    J Dermatol Sci; 2016 Nov; 84(2):149-159. PubMed ID: 27600927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of β-catenin promotes melanocyte specification at the expense of the Schwann cell lineage.
    Colombo S; Petit V; Wagner RY; Champeval D; Yajima I; Gesbert F; Aktary Z; Davidson I; Delmas V; Larue L
    Development; 2022 Jan; 149(2):. PubMed ID: 34878101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor.
    Widlund HR; Horstmann MA; Price ER; Cui J; Lessnick SL; Wu M; He X; Fisher DE
    J Cell Biol; 2002 Sep; 158(6):1079-87. PubMed ID: 12235125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal control of neural crest lineage generation by Wnt/β-catenin signaling.
    Hari L; Miescher I; Shakhova O; Suter U; Chin L; Taketo M; Richardson WD; Kessaris N; Sommer L
    Development; 2012 Jun; 139(12):2107-17. PubMed ID: 22573620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Xenopus cadherin-11 leads to increased Wnt/β-catenin signaling and up-regulation of target genes c-myc and cyclin D1 in neural crest.
    Koehler A; Schlupf J; Schneider M; Kraft B; Winter C; Kashef J
    Dev Biol; 2013 Nov; 383(1):132-45. PubMed ID: 23958437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Importance of MITF Signaling Pathway in the Regulation of Proliferation and Invasiveness of Malignant Melanoma].
    Urban P; Rabajdová M; Veliká B; Špaková I; Bolerázska B; Mareková M
    Klin Onkol; 2016; 29(5):347-350. PubMed ID: 27739313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
    Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
    Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SKI activates Wnt/beta-catenin signaling in human melanoma.
    Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
    Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
    Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of ICAT and Wnt signaling-related proteins in the monocytic differentiation of HL-60 cells induced by a new steroidal drug NSC67657].
    Wang JS; Wang WJ; Wang T; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):246-51. PubMed ID: 27087369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-catenin inhibits melanocyte migration but induces melanoma metastasis.
    Gallagher SJ; Rambow F; Kumasaka M; Champeval D; Bellacosa A; Delmas V; Larue L
    Oncogene; 2013 Apr; 32(17):2230-8. PubMed ID: 22665063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.
    Sinnberg T; Levesque MP; Krochmann J; Cheng PF; Ikenberg K; Meraz-Torres F; Niessner H; Garbe C; Busch C
    Mol Cancer; 2018 Feb; 17(1):59. PubMed ID: 29454361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.